Spaans F, et al. Danger signals from ATP and adenosine in pregnancy and preeclampsia. Hypertension. 2014;63(6):1154–60.
Rodrigues RJ, Marques JM, Cunha RA. Purinergic signalling and brain development. Semin Cell Dev Biol. 2019;95:34–41.
Burnstock G. P2X ion channel receptors and inflammation. Purinergic Signal. 2016;12(1):59–67.
CAS PubMed PubMed Central Google Scholar
Pelegrin P. P2X7 receptor and the NLRP3 inflammasome: Partners in crime. Biochem Pharmacol. 2021;187:114385.
Di Virgilio F, et al. The P2X7 Receptor in Infection and Inflammation. Immunity. 2017;47(1):15–31.
Yin W, Godbout JP, Sheridan JF. Chap. 7 - Interleukin-1 beta in psychosocial stress. Stress: immunology and inflammation. Academic; 2024;53–63. G. Fink, Editor.
Kaneko N, et al. The role of interleukin-1 in general pathology. Inflamm Regeneration. 2019;39(1):12.
Sutton CE, et al. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009;31(2):331–41.
Deverman BE, Patterson PH. Cytokines and CNS development. Neuron. 2009;64(1):61–78.
Hewett SJ, Jackman NA, Claycomb RJ. Interleukin-1β in central nervous system injury and repair. Eur J Neurodegener Dis. 2012;1(2):195–211.
PubMed PubMed Central Google Scholar
Fields RD. Nonsynaptic and nonvesicular ATP release from neurons and relevance to neuron-glia signaling. Semin Cell Dev Biol. 2011;22(2):214–9.
CAS PubMed PubMed Central Google Scholar
Koizumi S. Synchronization of Ca2 + oscillations: involvement of ATP release in astrocytes. Febs J. 2010;277(2):286–92.
George J, et al. Different danger signals differently impact on microglial proliferation through alterations of ATP release and extracellular metabolism. Glia. 2015;63(9):1636–45.
Bodin P, Burnstock G. Purinergic signalling: ATP release. Neurochem Res. 2001;26(8–9):959–69.
Chen YH, et al. Extracellular ATP is a homeostatic messenger that mediates Cell-Cell communication in physiological processes and psychiatric diseases. Biol Psychiatry. 2025;97(1):41–53.
Giuliani AL, Sarti AC, Di Virgilio F. Ectonucleotidases in acute and chronic inflammation. Front Pharmacol. 2020;11:619458.
Taruno A. ATP release channels. Int J Mol Sci. 2018;19(3):808.
PubMed PubMed Central Google Scholar
Burnstock G, Kennedy C. P2X receptors in health and disease. Adv Pharmacol. 2011;61:333–72.
North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82(4):1013–67.
Rodrigues RJ, Tomé AR, Cunha RA. ATP as a multi-target danger signal in the brain. Front Neurosci. 2015;9:148.
PubMed PubMed Central Google Scholar
Sperlágh B, Illes P. P2X7 receptor: an emerging target in central nervous system diseases. Trends Pharmacol Sci. 2014;35(10):537–47.
Bidula S, et al. Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages. Cell Death Dis. 2019;10(12):882.
PubMed PubMed Central Google Scholar
Purohit R, Bera AK. Pannexin 1 plays a pro-survival role by attenuating P2X7 receptor-mediated Ca2 + influx. Cell Calcium. 2021;99:102458.
Crespo Yanguas S, et al. Pannexin1 as mediator of inflammation and cell death. Biochimica et Biophysica Acta (BBA). - Mol Cell Res. 2017;1864(1):51–61.
Weilinger NL, et al. Pannexin-1 opening in neuronal edema causes cell death but also leads to protection via increased microglia contacts. Cell Rep. 2023;42(10):113128.
CAS PubMed PubMed Central Google Scholar
Boyce AKJ, Swayne LA. P2X7 receptor cross-Talk regulates ATP-induced pannexin 1 internalization. Biochem J. 2017;474(13):2133–44.
Ruan Z, et al. Structures of human pannexin 1 reveal ion pathways and mechanism of gating. Nature. 2020;584(7822):646–51.
CAS PubMed PubMed Central Google Scholar
Mim C, Perkins G, Dahl G. Structure versus function: are new conformations of pannexin 1 yet to be resolved? J Gen Physiol, 2021;153(5).
Baroja-Mazo A, Barberà-Cremades M, Pelegrín P. The participation of plasma membrane hemichannels to purinergic signaling. Biochim Et Biophys Acta - Biomembr. 2013;1828(1):79–93.
Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Therapy. 2021;6(1):291.
Acioglu C, Heary RF, Elkabes S. Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases. Behav Immun. 2022;102:163–78. Brain.
Kielian T. Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res. 2006;83(5):711–30.
CAS PubMed PubMed Central Google Scholar
Yang J, Yan H. TLR5: beyond the recognition of Flagellin. Cell Mol Immunol. 2017;14(12):1017–9.
CAS PubMed PubMed Central Google Scholar
Miyake K, et al. Nucleic acid sensing by Toll-Like receptors in the endosomal compartment. Front Immunol. 2022;13:941931.
CAS PubMed PubMed Central Google Scholar
Zhang Z, et al. Structural analyses of Toll-like receptor 7 reveal detailed RNA sequence specificity and recognition mechanism of agonistic ligands. Cell Rep. 2018;25(12):3371–e33815.
Semple C, et al. Polymorphisms in the P2X7 receptor, and differential expression of Toll-like receptor-mediated cytokines and defensins, in a Canadian Indigenous group. Sci Rep. 2019;9(1):14204.
PubMed PubMed Central Google Scholar
Zhang W-J, et al. NLRP3 inflammasome: A key contributor to the inflammation formation. Food Chem Toxicol. 2023;174:113683.
Yang Y, et al. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10(2):128.
PubMed PubMed Central Google Scholar
Zangiabadi S, Abdul-Sater AA. Regulation of the NLRP3 inflammasome by posttranslational modifications. J Immunol. 2022;208(2):286–92.
Karmakar M, et al. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP. Nat Commun. 2016;7:10555.
CAS PubMed PubMed Central Google Scholar
Próchnicki T, Mangan MS, Latz E. Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation. F1000Res, 2016;5.
Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–89.
CAS PubMed PubMed Central Google Scholar
Groß CJ, et al. K(+) Efflux-Independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity. 2016;45(4):761–73.
Comments (0)